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Abstract K-Tocopheryl succinate (K-TOS), but not K-toco-
pherol, triggered apoptosis in Jurkat T cells. Apoptosis was
induced by K-TOS in a time- and concentration-dependent mode,
and signs of apoptosis were visible at concentrations of K-TOS as
low as 30 WM, and within 3^5 h after addition of the ester.
Employing a specific fluorogenic substrate, caspase-3 was found
to be activated rapidly in response to K-TOS at 50 WM. We also
found that Jurkat T cells challenged with K-TOS, when exposed
to the lysosomotropic weak base acridine orange, showed
decreased lysosomal uptake of the dye. This is suggestive of
the involvement of lysosomal destabilisation in apoptosis of the
cells. Apoptosis of Jurkat T cells induced with K-TOS also
involved a drop in the mitochondrial membrane potential,
although this phenomenon occurred after the initiation of
lysosomal rupture. All apoptotic features observed with K-TOS
were very similar to those found when cross-linking of the Fas
receptor triggered apoptosis. These findings are consistent with
the recent idea that vitamin E can contribute to elimination of
malignant cells by the induction of apoptosis, and can be of
(patho)physiological significance.
z 1999 Federation of European Biochemical Societies.
Key words: Vitamin E; Caspase; Mitochondria;
Lysosomal destabilisation; T lymphocyte; Apoptosis
1. Introduction
Apoptosis is a form of death in which a cell destroys itself
in a regulated sequence of events without poisoning the neigh-
bouring cells or by causing an in£ammatory response [1]. A
number of triggers have been reported to induce apoptosis,
and these include both immunological and chemical stimuli
[2]. Of the former, cross-linking of the Fas receptor has been
studied intensively over the recent period. The generalised
scheme is such that engagement of the Fas ligand results in
recruitment of the proteolytic pro-caspase-8 (FLICE) to the
death domain on the cytosolic side of the Fas receptor [3]
followed by its activation that, in turn, leads to the activation
of caspase-3 (CPP32). This protease is supposed to directly
cleave the so-called death substrates, such as the lamins, K-
fodrin or poly(ADP-ribose)polymerase, the consequences of
which, in a still only partially understood way, are the irre-
versible cleavage of the genomic DNA and death of the cell
[4].
One of the important features of apoptosis is that not all
cell types respond to the various stimuli with the same sensi-
tivity. Sometimes, transformed cell lines as well as malignant
cells isolated from tumours are more sensitive to pro-apop-
totic stimuli than normal cells. In line with this concept, there
is a limited number of reports showing that certain forms of
vitamin E, such as K-tocopheryl succinate (K-TOS) or Trolox
(a water-soluble analogue of K-tocopherol) trigger or poten-
tiate apoptotic cell death in several transformed cell lines,
including a chicken reticuloendotheliosis virus-transformed
cell line [5] and colon carcinoma cell lines [6].
Prompted by its potential (patho)physiological relevance,
we studied whether di¡erent forms of vitamin E are capable
of inducing programmed cell death in the apoptosis-sensitive
Jurkat T (JT) lymphoma cell line. Here we show that K-toco-
pheryl succinate (K-TOS), but not K-tocopherol (K-TOH),
triggers apoptosis in JT cells, and that this involves both cas-
pase activation, lysosomal destabilisation, and changes in mi-
tochondrial membrane potential.
2. Materials and methods
2.1. Cell culture
Jurkat T cells (line EG.1, European Collection of Animal Cell Cul-
tures, Salisbury, UK) were grown in RPMI-1640 with 10% foetal calf
serum (FCS), 2 mM glutamate, 100 U/ml penicillin and 100 Wg/ml
streptomycin, at 37‡C, in humidi¢ed air with 5% CO2. Every 3 days,
the rapidly growing cells were split with fresh medium to the density
of about 0.5U106 cells/ml. For the experiments, cells were seeded in
Falcon 6-well plates at 0.5U106 cells/ml in the complete medium, and
treated as detailed below.
K-D-tocopheryl succinate (K-TOS; Sigma, St. Louis, MO, USA) or
K-D-tocopherol (K-TOH; Sigma) was added to the cells as EtOH
solution at concentrations of 0^50 WM so that the volume of EtOH
added to the culture medium was 6 0.5% (v/v). The anti-human Fas/
APO-1/CD95 monoclonal antibody (CH-11; Oncor, Gaithersburg,
MD, USA, or Coulter-Immunotech Diagnostics, Hamburg, Germany)
was added to the cells at 20 ng/ml. The control cultures, with no
vitamin E or anti-Fas IgM added, were supplemented with the corre-
sponding volume of the vehicle. Cells were exposed to K-TOS or K-
TOH for up to 24 h and to anti-Fas IgM for 6 h.
2.2. Assessment of apoptosis
Apoptosis was assessed by means of visual evaluation in a light
microscope of changes in the cytoarchitecture, such as budding mem-
branes and pycnotic or fragmented nuclei. This was done either di-
rectly in a Rosenthal chamber, or after staining of the cells. Brie£y,
cells were ¢xed in 4% neutral-bu¡ered formalin and stained with a
0.5% Giemsa solution (Merck, Dartmstadt, Germany) [7]. The annex-
in-V cell surface labelling method [8] was also used. For this, 1U106
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cells were labelled on ice for 10^15 min in 0.1 ml incubation bu¡er
containing 10 mM HEPES, 140 mM NaCl, 5 mM CaCl2, pH 7.4, plus
20 Wl annexin-V conjugated to £uorescein isothiocyanate (FITC;
Boehringer Mannheim, Germany) and 50 Wl of 50 Wg/ml propidium
iodide (PI; Sigma). The cells were washed, centrifuged, resuspended in
the incubation bu¡er and analysed by £uorescence-activated cell sort-
ing (FACS; Becton-Dickinson, San Jose, CA, USA). The data were
evaluated using the CellQuest software. DNA laddering was per-
formed as described in [9]. Brie£y, genomic DNA was isolated [10]
and then subjected to electrophoresis on a 2% agarose gel. The DNA
bands were visualised by ethidium bromide staining and evaluated by
comparison with a 100-base pair DNA ladder standard.
2.3. Measurement of caspase-3 activity
The method of Nicholson et al. [11] was used employing the £uo-
rogenic substrate for caspase-3, Ac-DEVD-AMC (Pharmingen, San
Diego, CA, USA). Brie£y, W0.5U106 cells were pelleted and lysed
with 150 Wl of lysis bu¡er comprising 10 mM Tris-HCl, pH 7.5, 130
mM NaCl, 1% Triton and 10 mM NaH2PO4. 100 Wl of the cell lysate
were combined with 1 ml of the reaction bu¡er consisting of 20 mM
HEPES, pH 7.5, 10% glycerol, 2 mM dithiothreitol and 20 WM Ac-
DEVD-AMC, and incubated at 37‡C for 2 h. The intensity of £uo-
rescence of the liberated amino-4-methylcoumarin (AMC) was then
measured (Vex = 380 nm, Vem = 435 nm).
2.4. Assessment of mitochondrial potential
Changes in inner mitochondrial membrane potential (v8m) in JT
cells following di¡erent treatments were assessed as reported elsewhere
[12]. In brief, the cells were centrifuged, resuspended in PBS contain-
ing 0.5% FCS, and incubated for 15 min at 37‡C with 40 nM 3,3P-
dihexyloxacarbocyanine iodide (DiOC6 ; Molecular Probes, Eugene,
OR, USA). Immediately before measuring in the £ow cytometer,
1 Wg/ml PI was added. As a positive control, cells were also incubated,
prior to the DiOC6 and PI addition, for 15^30 min with 50 nM
carbonylcyanide-3-chlorphenylhydrazone (CCCP).
2.5. Lysosomal stability assessment
Cells in various stages were assessed for lysosomal stability using
the acridine orange (AO) uptake method [13]. Washed cells
(W0.5U106) were pelleted and resuspended in 2.5 ml complete culture
medium with 10 mM HEPES supplemented with 5 Wg/ml AO, incu-
bated at 37‡C for 15 min, washed, pelleted, and resuspended in 100 Wl
PBS for static cytometry and in 0.5 ml PBS for £ow cytometry. Static
cytometric evaluation of the AO-labelled cells was performed in a
Nikon Microphot SA microscope equipped with a ¢lter cube for green
excitation and an extra 630-nm barrier ¢lter, where 100 randomly
selected cells were scored for red £uorescence intensity. The cells
were also examined in an LSM 410 inverted confocal laser scanning
microscope (Carl Zeiss). To evaluate randomly selected higher num-
ber of cells (10 000 per each run), the cells were subjected to assess-
ment for AO £uorescence intensity using the FACS instrument ¢tted
with the Lysis II software.
3. Results and discussion
To test whether vitamin E derivatives induce apoptosis in
JT cells, we exposed the cells, seeded at a density below that
which was found to trigger ‘spontaneous’ apoptosis [14], to
increasing concentrations of K-TOS and K-TOH for 24 h. As
shown in Fig. 1A, apoptosis occurred at concentrations of K-
TOS as low as 30 WM, as assessed by visual evaluation of the
Giemsa-stained cells, while no apoptosis was observed with K-
TOH even at 50 WM. These observations were con¢rmed by
assessment of genomic DNA fragmentation in K-TOS- and K-
TOH-exposed cells (Fig. 1B). As a positive control, cross-link-
ing of the Fas receptor with anti-Fas IgM was used which
asserted features of apoptosis similar to those observed for
K-TOS (cf. Fig. 1A, B).
Fig. 2 shows the time dependence of apoptosis induced by
50 WM K-TOS in JT cells. The ¢rst signs of apoptosis, as
documented by microscopic evaluation of the Giemsa-stained
cells (A) and by DNA laddering (B), were evident as early as
3 h following the exposure of the cells to the ester. Apoptosis
was also assessed by the annexin-V-FITC-labelling method
(Fig. 2C), which is based on binding of annexin-V to phos-
phatidyl serine initially present in the inner lea£et of the cell
membrane when exposed to the surface the cell enters apop-
tosis [8]. As shown also in Fig. 2B, C, apoptosis was evident
in cells treated with 50 WM K-TOS for 24 h or with 20 ng/ml
anti-Fas IgM for 6 h. Virtually no apoptosis was apparent in
control cells and in cells exposed to 50 WM K-TOH for 24 h.
Another typical feature of apoptosis is the functional acti-
vation of caspases, a group of proteolytic enzymes that are
involved in transmitting the early pro-apoptotic signals, such
as engagement of the Fas receptor, to the later events that
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Fig. 1. E¡ect of increasing concentration of vitamin E on apoptosis in JT cells. JT cells were cultured at 0.5U105 per ml in complete RPMI
for 24 h in the presence of increasing concentrations of K-TOS, K-TOH (WM) or anti-Fas IgM (ng/ml), and evaluated for apoptotic morphology
using the Giemsa staining method (A), and for DNA laddering (B); lane 1, control; lane 2, 20 ng/ml anti-Fas for 6 h; lane 3, 50 WM K-TOH
for 24 h; lanes 4^7, K-TOS for 24 h at 20, 30, 40 and 50 WM, respectively; lane 8, 100 bp DNA ladder standard. The data shown in A are
average values þ S.D. (n = 4 for K-TOS and K-TOH, n = 3 for anti-Fas IgM), the images in B are typical representatives of three independent ex-
periments.
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include cleavage of the so-called death substrates, i.e. proteins
associated directly with the stabilisation and/or repair of the
genomic DNA. While the function of some of the known
caspases has not been clearly established yet [15], activation
of caspase-3 appears to be crucial in cells undergoing apop-
tosis [16]. Consistent with this notion, we observed activation
of caspase-3 as early as 3 h after the exposure of JT cells to
50 WM K-TOS. The activity of the protease was maximal at
about 12 h, and this was then followed by its slow decline
(Fig. 3). As expected, substantial caspase-3 activity was ob-
served when the cells were exposed to 20 ng/ml anti-Fas IgM
for 6 h, but no caspase-3 activity was apparent upon treat-
ment with 50 WM K-TOH for 24 h. The observation that K-
TOS-induced apoptosis in JT cells involves caspase-3 activa-
tion is consistent with a recent report according to which
several anti-cancer drugs induced apoptosis in cancer cells
by activating caspase-3 [17].
Apoptosis induced with anti-Fas IgM or by oxidative stress
involves changes in the mitochondrial membrane potential
(v8m) [18,19]. To see whether this is also the case for vitamin
E-induced apoptosis in JT cells, we exposed the cells to the
stimulus and assessed v8m using the £uorogenic dye DiOC6.
As shown in Fig. 4, signi¢cant v8m dissipation was observed
upon exposure of the cells to 50 WM K-TOS for 12 h, but not
to K-TOH, and the change was accompanied by a signi¢cant
increase in the population of apoptotic cells. Similar results
were achieved when the cells were treated with anti-Fas IgM.
The protonophore CCCP was used as a positive control in
these experiments as it brings down v8m (cf. Fig. 4).
It has been reported recently that apoptosis of lymphoid
cells triggered with anti-Fas IgM, oxidative stress and growth
factor starvation, i.e. unrelated stimuli, involves the destabili-
sation of lysosomes [9] and that the ‘acidic compartment’ is of
importance for cells during apoptosis [20]. To investigate
whether such lysosomal rupture would also occur in apoptosis
induced in JT cells by their exposure to vitamin E, we stained
the cells with AO after treatment with increasing concentra-
tions of K-TOS or K-TOH at a set point of time, or with
K-TOS or K-TOH at 50 WM for increasing periods of time.
A short-term exposure of cells to AO results in a high con-
centration of the lysosomotropic weak base in lysosomes, un-
less they are destabilised. Hence, upon lysosomal ‘rupture’ or
‘leakage’, AO, normally localised in the acidic vacuolar appa-
ratus as shown by strong granular, red £uorescence, trans-
locates to the cytoplasm, and the cells appear ‘pale’ with a
signi¢cantly reduced number of intact lysosomes [9]. Fig. 5
shows that lysosomes were destabilised in JT cells treated
with K-TOS or with anti-Fas IgM. This is illustrated by the
imaging of both apoptotic and non-apoptotic cells by £uores-
cence confocal microscopy (A) and by £ow cytometry (B^D).
As with the apoptotic markers (see above), lysosomal destabi-
lisation in JT cells with K-TOS was similar to that with anti-
Fas IgM, while no destabilisation was seen with K-TOH. The
time dependence of lysosomal destabilisation resembled that
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Fig. 2. Time-dependent induction of apoptosis in JT cells exposed to K-TOS. The cells were seeded at 0.5U106 per ml in complete RPMI and
supplemented with 50 WM K-TOS, 50 WM K-TOH or 20 ng/ml anti-Fas IgM at di¡erent time points so that the end point for all treatments
was simultaneous. Cells were analysed for apoptosis by visual microscope evaluation after Giemsa staining (A), DNA laddering (B) (lane 1,
control; lane 2^7, 50 WM K-TOS for 3, 6, 9, 12, 18 and 24 h, respectively; lane 8, 100 bp DNA ladder standard), and annexin-V-FITC binding
(C). Images shown in B and C are representative examples of at least three independent experiments, data in A are mean values þ S.D. (n = 4).
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of the apoptotic markers in cells exposed to K-TOS, although,
at earlier time points (e.g. at 3 h) only few lysosomes appeared
to be a¡ected (cf. Fig. 5C). It is plausible to suggest, similarly
as in [9] or [21], that only a relatively small fraction of lyso-
somes needs to become leaky in order to release su⁄cient
amounts of lytic enzymes to activate the pro-apoptotic cas-
cade of events. Cathepsin D is one of the proteases that re-
localises upon lysosomal disruption and that could activate
the caspase pathway, as has been suggested [7,9,21,22]. Re-
cently, however, it was shown that the cysteine proteases cath-
epsin B and L had the capacity to activate caspase-3 following
lysosomal permeabilisation [23].
It is an intriguing question why all the e¡ects observed here
were induced with K-TOS but not with the non-esteri¢ed,
redox-active form of the vitamin. It has been reported that
K-TOS, but not K-TOH or K-tocopheryl acetate, inhibited
adhesion of monocytes to endothelial cells by inhibiting acti-
vation of the nuclear factor-UB [24]. Similar observations have
been reported elsewhere [5], and the authors argued against
the involvement of the redox function of the vitamin. Simi-
larly, Azzi and associates [25] suggested that K-TOH-induced
inhibition of smooth muscle cell proliferation was unrelated to
the redox function of the vitamin, and was receptor-mediated.
Whether the redox properties of vitamin E derivatives are
important for their role in apoptosis induction is unclear at
the moment. However, a recent report has shown that in a
colon cancer cell line, low levels of reactive species, presum-
ably involved in proliferation of the cells, were depleted upon
treatment with Trolox, a redox-active, water-soluble K-TOH
analogue, and this resulted in massive apoptosis [6].
While we believe that the redox function of K-TOS can play
a role in JT cell apoptosis (vitamin E can exert both pro- and
antioxidant activities [26]), it is also possible that inhibitory
activity of vitamin E on protein kinase C (PKC), an impor-
tant factor regulating cell proliferation, can be involved in
vitamin E-induced apoptosis. This assumption is based on
reports that show vitamin E to inhibit various functions in
smooth muscle, endothelial and monocytic cells associated
with proliferation/in£ammation by inhibiting PKC
[25,27,28]. Interestingly, Qiang et al. [5] have shown that in
an avian reticuloendotheliosis virus-transformed T-cell line, K-
TOS induced apoptosis via transformed growth factor-L sig-
nalling. This led to activation of c-fos and c-jun, and subse-
quently increased binding of the activator protein-1 (that can
result in an inactivation of PKC [25]), and downregulation of
the protooncogene c-myc. Interestingly, an apoptotic pathway
induced by anti-Fas IgM, independent of caspases, that in-
volves the Daxx adapter protein and leads to activation of
transcription factors, such as c-jun, has been recently de-
scribed [29]. Notwithstanding, it should be stressed that the
involvement of PKC inactivation in apoptosis has been estab-
lished (see e.g. [30^32]). Studies are under way in order to
establish links between K-TOS-induced apoptosis in JT cells
and the early and later signals as shown in this communica-
tion and by others, viz. the activation of caspases, and desta-
bilisation of lysosomes due to changes in their membrane
permeability (see e.g. [19,33,34]).
To conclude, we document in this study that: (i) K-TOS,
but not K-TOH, induces apoptosis in JT cells as documented
by three independent methods; (ii) K-TOS-induced apoptosis
involves caspase-3 activation, and both lysosomal and mito-
chondrial destabilisation; and (iii) the features shown for K-
TOS-triggered apoptosis in JT cells closely resemble those
observed for apoptosis induced by anti-Fas IgM. Hence, our
results are consistent with the idea that certain compounds of
potential pharmacological relevance, as shown here for
K-tocopheryl succinate, can induce apoptotic cell death in
transformed cells. Studies are under way to establish whether
K-TOS and other derivatives of vitamin E can induce apop-
tosis also in other cell lines and in cells isolated from tumour
biopsies, and to elucidate the molecular mechanism of such
vitamin E-induced apoptosis.
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Fig. 3. Apoptosis in JT cells induced with K-TOS involves caspase-3
activation. Cells, seeded at 0.5U106 per ml, were cultured in com-
plete RPMI in the presence of 50 WM K-TOS, 50 WM K-TOH or 20
ng/ml anti-Fas IgM for di¡erent time periods, and analysed for cas-
pase-3 activity using the £uorogenic substrate Ac-DEVD-AMC as
detailed in Section 2. The numbers at the individual additives at the
x-axis indicate the time of exposure in h. The data shown are mean
values þ S.D. (n = 3).
Fig. 4. Apoptosis in JT cells involves changes in the mitochondrial
inner membrane potential. The cells were grown at 0.5U106 per ml
in complete RPMI and treated for 12 h with vitamin E derivatives
at 10 or 50 WM, or for 6 h with anti-Fas IgM at 20 ng/ml. Cells ex-
posed to 50 nM CCCP were used as positive control. The cells were
then labelled with DiOC6 and PI and v8m dissipation estimated by
£ow cytometry as detailed in Section 2. The bar graph shows aver-
age values þ S.D. (n = 3^5) of the percentage of the v8m low cells.
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Fig. 5. Apoptosis in JT cells induced with K-TOS involves lysosomal destabilisation. The cells, seeded at 0.5U106 per ml complete RPMI, were
treated with K-TOS, K-TOH or anti-Fas IgM at concentrations and for periods indicated at the individual ¢gures, harvested, and incubated
with AO as detailed in Section 2. After the incubation (within 15 min), the cells were analysed for red £uorescence using the confocal micro-
scope (A: exposure to 50 WM K-TOS or K-TOH for 24 h, or to 20 ng/ml anti-Fas IgM for 6 h) or £ow cytometry (B: increasing concentrations
of K-TOS or K-TOH for 24 h; C: di¡erent time periods of treatment with 50 WM K-TOS or K-TOH). The images shown in A are representa-
tive examples of at least two independent experiments, the data in B and C are mean values þ S.D. (n = 3). Images of the £ow cytometer scans
representing selected samples, as indicated by the text at the individual graphs, are shown in D.
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